MedPath

NEURODIAB CAPSULE

Registration Number: MAL24076097NC

Approved
Approval ID

8460b3b7547d0372

Registration Number

MAL24076097NC

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types6 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (6)

10 CapsulesAvailable
Package Size: 10 Capsules
Status: NPRA Approved
30 CapsulesAvailable
Package Size: 30 Capsules
Status: NPRA Approved
60 CapsulesAvailable
Package Size: 60 Capsules
Status: NPRA Approved
90 CapsulesAvailable
Package Size: 90 Capsules
Status: NPRA Approved
180 CapsulesAvailable
Package Size: 180 Capsules
Status: NPRA Approved
120 CapsulesAvailable
Package Size: 120 Capsules
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (5)

FOLIC ACIDActive
Monograph: 叶酸
Magnesium bisglycinateActive
Monograph: magnesium bisglycinate
METHYLCOBALAMINActive
Monograph: 甲钴胺
Vitamin D3 (Cholecalciferol)Active
Monograph: vitamin d 3 (cholecalciferol)
CHROMIUM POLYNICOTINATEActive
Monograph: chromium polynicotinate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NEURODIAB CAPSULE - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform